Quick Takeaways:
- Zenex Animal Health has acquired the SAVAVET companion animal business from SAVA Healthcare, marking its third strategic acquisition since partnering with Multiples Alternate Asset Management, following Ayurvet and VievePharm.
- SAVAVET brings a portfolio of ~70 brands spanning parasiticides, antibiotics, cardiac care, pain management, dermatology and wellness, along with established veterinarian relationships and distribution across India, strengthening Zenex’s companion animal franchise.
- The acquisition expands Zenex’s presence across livestock, poultry, companion animals and herbal healthcare, while SAVA Healthcare will focus on human health formulations, R&D, contract manufacturing and international business, retaining its farm animal business.
Why It Matters?
Zenex’s acquisition of SAVA’s SAVAVET companion‑animal business (~70 brands; ~165 stockists; relationships with 6,000+ veterinarians) instantly scales its pet‑care franchise in India—one of the fastest‑growing animal‑health segments driven by rising pet ownership and preventive‑care spend—and complements prior deals (Ayurvet, VievePharm) to build a diversified platform across livestock, poultry, companion animals and herbal/natural products.
Source: Zenex















